IGM Biosciences to Present at the Jefferies 2020 Healthcare Conference
May 28 2020 - 7:00AM
IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage
biotechnology company focused on creating and developing engineered
IgM antibodies, today announced that Fred Schwarzer, Chief
Executive Officer, will present at the Jefferies 2020 Healthcare
Conference on Thursday, June 4 at 10:00 a.m. ET. The conference
will be held in a virtual meeting format.
A live webcast of the event will be available on the “Events and
Presentations” page in the “Investors” section of the Company’s
website at
https://investor.igmbio.com/news-and-events/events-and-presentations.
A replay of the webcast will be archived on the Company’s website
for 90 days following the presentation.
About IGM Biosciences, Inc. Headquartered in
Mountain View, California, IGM Biosciences is a clinical-stage
biotechnology company focused on creating and developing engineered
IgM antibodies. Since 2010, IGM Biosciences has worked to overcome
the manufacturing and protein engineering hurdles that have limited
the therapeutic use of IgM antibodies. Through its efforts, IGM
Biosciences has created a proprietary IgM technology platform for
the development of IgM antibodies for those clinical indications
where their inherent properties may provide advantages as compared
to IgG antibodies.
Contact:
Argot Partners David Pitts212-600-1902
igmbio@argotpartners.com
IGM Biosciences (NASDAQ:IGMS)
Historical Stock Chart
From Jul 2024 to Aug 2024
IGM Biosciences (NASDAQ:IGMS)
Historical Stock Chart
From Aug 2023 to Aug 2024